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Abstract
Blood transfusion is currently one of the most important health care treatments. Unfortunately, the
prevalence of transfusion reactions caused by the use of blood products is still quite high although
blood products have been tested in terms of infectious diseases using 4 parameters, namely
hepatitis B, hepatitis C, HIV and syphilis. The results of the analysis of blood products produced
by UTD (Blood Transfusion Unit) Surabaya showed bacterial contamination of blood products,
starting from normal skin flora to pathogens. Bacterial contamination is also believed to be one of
the causes of transfusion reactions. Therefore, it is necessary to make efforts to prevent bacterial
contamination of blood products. One of the efforts is to find chemical compounds that have good
antibacterial activity. In this study, the antibacterial activity of 2 ˈ -hydroxy-4 ˈ ,6
ˈ ,4-trimethoxychalcone and 4-methoxychalcone was tested against gram positive and gram
negative bacteria. The test method was agar diffusion at various concentrations of chalcone,
namely 0.625; 1.25; 2.5 and 5.0%. The results showed that both chalcones had good antibacterial
activity against gram-positive and gram-negative bacteria.
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1. Introduction
The use of various blood products such as
whole blood; packed red cells or thrombocyte
concentrate as drug preparations has increased
over year (Darmawan and Irawan, 2015). Blood
transfusions are performed in various medical
conditions such as chronic anemia, blood loss
(Thalassemia, Hemophilia, Leukemia and
Thrombocytopenia) and massive bleeding
(trauma, surgical processes, DIC, GI bleeding
and baby delivery (Booth et al., 2017). The vital
role of blood transfusions in clinical practice is
inseparable from various risks such as acute
hemolytic, bacterial infection, acute lung injury,
accumulation of interstitial fluid in the lungs,
severe allergic reactions and anaphylaxis
(Delaney et al., 2016). Analysis of bacteria in
blood products may reduce transfusion risks due
to bacterial contamination (Kusumaningrum and
Sepvianti, 2018).
The results of blood product analysis
carried out at UTD (Blood Transfusion Unit) of
PMI (Red Cross) Surabaya showed bacterial
contamination in various blood products such as
whole blood and thrombocyte concentrate. Some
of the species of the bacterial contaminants
found are: Sphingomonaspaucimobilis;
Propionibacterium acnes; Staphylococcus
hominis;
Fusobacteriumvarium;Prophyromonasassacchar
olytica; and Staphylococcus aureus
(Tjiptoprajitno et al, 2012). In addition, another
study found Escherichia coli in whole blood
(Alizadeh et al, 2017). Bacterial contaminants
consist of both gram positive and gram negative.
Besides, most of the bacteria are normal skin
flora and pathogens such as Staphylococcus
aureus and Escherichia coli.
Based on such description, it is
understandable that currently efforts shall be
made to prevent bacterial infections in blood
products. One of the efforts that can be made is
to find chemical compounds that have good
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antibacterial activity. One compound that is
often reported to have good biological activity is
chalcone (Sepvianti, 2016). This study tested the
antibacterial activity of 2 ˈ -hydroxy-4 ˈ ,6
ˈ ,4-trimethoxychalcone and 4-methoxychalcone
against gram positive bacteria (Staphylococcus
aureus) and gram negative ones (Escherichia
coli).
2. Method
The antibacterial activity of
2’-hydroxy-4’,6’,4-trimethoxychalcone and
4-methoxychalcone was tested using agar
diffusion method by measuring the clear zone
which indicates the inhibitory power of the
compounds. The bacteria used were Escherichia
coli (Gram Negative) and Staphylococcus aureus
(Gram Positive). The method to test the
antibacterial activity referred to Setyawati, et al
(2017).
Materials
2’-hydroxy-4’,6’,4-trimethoxychalcone,4-me
thoxychalcone, nutrient broth, distilled water,
agar, 70% alcohol, Brain-Heart Infusion (BHI),
antibiotics, DMSO, culture of gram positive
bacteria Staphylococcus aureus ATCC, and
culture of gram negative bacteria Escherichia coli
ATCC.
Making solution to test chalcone
The test solution was made by dissolving
chalcone in DMSO at various concentrations,
namely 0.625; 1.25; 2.5 and 5%.
Sterilizing equipment
The equipment was sterilized using an
autoclave at a temperature of 121ºC under a
pressure of 15 atm for 15 minutes. Equipment
which could not be heat-sterilized was sterilized
using 70% alcohol.
Making agar base
2.8 g of nutrient broth powder was
dissolved in distilled water until the volume was
100 mL. The solution was heated until the
powder was completely dissolved, then
sterilized using autoclave.
Bacterial rejuvenation
A total of 0.24 g of nutrient broth was
dissolved in 30 mL of distilled water. The
solution was then poured into 5 reaction tubes;
each of the tubes contained 6 mL of NB solution.
Afterwards, they were sterilized using an
autoclave at a temperature of 121°C under a
pressure of 15 atm for 15 minutes. Each of the
tubes was filled with 3 mL of Staphylococcus
aureus and Escherichia coli, then incubated at
37°C for 24 hours.
Making bacterial media
Each petri dish was filled with 1000 μL
Staphylococcus aureus and Escherichia coli
resulted from the bacterial rejuvenation. The
agar solution was poured into the petri dish
which had been filled with the media base and a
ring was put on it. The petri dish was then
covered and left for some time. The ring was
removed when the agar had solidified, so an
agar well was formed.
Sample injection and measurement of inhibition
zone
25 μL of the test samples at concentrations of
0.625; 1.25; 2.5 and 5% was poured into the well.
The positive control was chloramphenicol and
the negative one was DMSO. Incubation was
carried out for 24 hours, followed by
measurement of inhibition zone. The diameter of
the inhibition zone was measured using a caliper
to determine antibacterial activity.
3. Result and Discussion
Both of these compounds were dissolved in
DMSO at various concentrations, namely 0.625;
1.25; 2.5 and 5.0%. In addition to functioning as
solvent, DMSO also served as the negative
control, while chloramphenicol as the positive
control. The bacteria used for the test were
Staphylococcus aureus ATCC (Gram Positive)
and Escherichia coli ATCC (Gram negative),
both of which were pathogens which were
reported to contaminate blood products. The
results of the antibacterial activity test on
2’-hydroxy-4’,6’,4-trimethoxychalcone and
4-methoxychalcone are presented in Table 1.
Tabel 1. Antibacterial Data Of Chalcone
Conc.
(%)
Zone of inhibition (mm)
2’-hydroxy-4’,6’,4-
trimethoxychalcone
4-
methoxychalcone
S.aureus E.coli S.aureus E.coli
0.625 2.7 0.1 5.3 0.5
1.25 2.4 0.8 9.1 1.1
2.5 4.6 2.2 5.7 1.6
5.0 8.0 14.0 6.3 10.0
Control
(+)
18.0 13.0 18.0 13.0
Control
(-)
- - - -
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A compound is stated to be an antibacterial
agent if it has an inhibition zone greater than 6.0
mm (Sepvianti and Kusumaningrum, 2019). In
this study, both chalcones showed good
antibacterial activity with inhibition zones
greater than 6.0 mm at certain concentrations.
2’-hydroxy-4’,6’,4-trimethoxychalcone had
good inhibitory power at a concentration of 5.0%
with an inhibition zone diameter greater than 6.0
mm, i.e. 8.0 mm on Staphylococcus aureus and
14.0 mm on Escherichia coli. The inhibitory
power shown by
2’-hydroxy-4’,6’,4-trimethoxychalcone against
Escherichia coli was far better than that by the
antibiotic control, with a difference in the
inhibition zone diameter of 1.0 mm.
4-methoxychalcone also showed similar
results: at a concentration of 5.0% this compound
had a diameter of inhibition zone greater than
6.0 mm, i.e. 6.3 mm on Staphylococcus aureus
and 10.0 mm on Escherichia coli. In addition, at a
concentration of 1.25% this compound showed
greater inhibitory power, i.e. 9.1 mm, against
Staphylococcus aureus.
Based on these observations,
2’-hydroxy-4’,6’,4-trimethoxychalcone had
larger inhibition zone compared to
4-methoxychalcone. This is supposedly due to
differences in the types and number of functional
groups bound to these two compounds.
2’-hydroxy-4’,6’,4-trimethoxychalcone bound
hydroxyl and methoxy groups in ring A and ring
B, while 4-methoxychalcone only had methoxy
group in Ring B. The structure of chalcones is
shown in Figure 1.
Figure 1. Structure of Chalcone
Both chalcones had methoxy bound to these
two groups which had been reported as an active
antibacterial compound. Nonetheless, only
2’-hydroxy-4’,6’,4-trimethoxychalcone had
hydroxyl in Ring A. This group was thought to
increase the antibacterial activity of
2’-hydroxy-4’,6’,4-trimethoxychalcone because
hydroxyl group is known to have the ability to
dissolve lipids in the outer membranes of gram
negative bacteria which then damages
membranes, thus disrupting bacterial defense.
4. Conclusion and Suggestion
It can be concluded that 2 ˈ -hydroxy-4 ˈ ,6
ˈ ,4-trimethoxychalcone and 4-methoxchalcone
have good antibacterial activity against gram
positive bacteria (Staphylococcus aureus) and
gram negative bacteria (Escherichia coli). Both
compounds have the potential to be developed
as antibacterial compounds.
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